In 2023, China and India exhibited remarkable growth in top-cited scientific publications within endocrinology, diabetes, and metabolism, with 31.54% and 32.36% increases, respectively. The United States, Italy, and the United Kingdom maintained steady contributions, while countries like Saudi Arabia and Indonesia showed significant percentage increases, above 30%. European countries such as Germany and the Netherlands presented lower growth, with slight or negative variations. Meanwhile, emerging economies like Brazil and Mexico displayed moderate growth rates, indicative of their increasing research capabilities.
Looking forward, countries such as Indonesia, Saudi Arabia, and Croatia, which are experiencing substantial growth rates, will likely continue contributing prominently to the global research landscape in these fields. China's continued leadership, combined with India's increasing focus on scientific research, suggests both will remain key players in global scientific contributions in endocrinology, diabetes, and metabolism. Watch for collaborations and technological advancements driving publication volumes in under-represented regions.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Endocrinology, Diabetes and Metabolism by Country
| # | 10 Countries | Units (Publications) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 315.8 | 2023 | +21.57% | +31.54% | View data |
| 2 | 2 United States | 251.91 | 2023 | +0.11% | +1.27% | View data |
| 3 | 3 Italy | 177.84 | 2023 | +18.71% | +25.38% | View data |
| 4 | 4 United Kingdom | 74.2 | 2023 | +2.27% | +5.01% | View data |
| 5 | 5 India | 48.15 | 2023 | +5.98% | +32.36% | View data |
| 6 | 6 Germany | 40.32 | 2023 | +0.98% | +1.71% | View data |
| 7 | 7 Australia | 34.53 | 2023 | +2.75% | -0.52% | View data |
| 8 | 8 Canada | 32.2 | 2023 | +0.19% | +0.26% | View data |
| 9 | 9 Japan | 31.88 | 2023 | +3.59% | +3.27% | View data |
| 10 | 10 South Korea | 29.17 | 2023 | +11.5% | +0.2% | View data |
